|
| 37818983 | Mean global DNA methylation serves as independent prognostic marker in IDH-wildtype glioblastoma. | Neuro Oncol | 2024 |
| 37818983 | Mean global DNA methylation serves as independent prognostic marker in IDH-wildtype glioblastoma. | Neuro Oncol | 2024 |
| 38008033 | A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma. | Eur J Cancer | 2024 |
| 37875569 | Author Correction: Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology. | Nat Med | 2024 |
| 38008033 | A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma. | Eur J Cancer | 2024 |
| 37875569 | Author Correction: Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology. | Nat Med | 2024 |
| 35977048 | BH3 mimetics targeting BCL-XL impact the senescent compartment of pilocytic astrocytoma. | Neuro Oncol | 2023 |
| 36356895 | Rare embryonal and sarcomatous central nervous system tumours: State-of-the art and future directions. | Eur J Med Genet | 2023 |
| 36271929 | Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1. | Acta Neuropathol | 2023 |
| 35868257 | DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patients. | Neuro Oncol | 2023 |
| 35977048 | BH3 mimetics targeting BCL-XL impact the senescent compartment of pilocytic astrocytoma. | Neuro Oncol | 2023 |
| 37609137 | Epigenetic neural glioblastoma enhances synaptic integration and predicts therapeutic vulnerability. | bioRxiv | 2023 |
| 38026572 | Reference on copy number variations in pleomorphic xanthoastrocytoma: Implications for diagnostic approach. | Free Neuropathol | 2023 |
| 37737691 | A Novel Type of IDH-wildtype Glioma Characterized by Gliomatosis Cerebri-like Growth Pattern, TERT Promoter Mutation, and Distinct Epigenetic Profile. | Am J Surg Pathol | 2023 |
| 37561227 | Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype: case series of a new entity. | Brain Tumor Pathol | 2023 |
| 37348162 | DNA methylation-based classifier differentiates intrahepatic pancreato-biliary tumours. | EBioMedicine | 2023 |
| 37279174 | Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline. | Neuro Oncol | 2023 |
| 36959034 | Corrigendum to 'Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry' [Eur J Cancer 180 (2023) 71-84]. | Eur J Cancer | 2023 |
| 37075810 | LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patients. | Neuro Oncol | 2023 |
| 36632791 | EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection. | Neuro Oncol | 2023 |
| 37183219 | Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells. | J Neurooncol | 2023 |
| 36542877 | Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry. | Eur J Cancer | 2023 |
| 36928815 | Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology. | Nat Med | 2023 |
| 36734226 | Adult intracranial ependymoma-relevance of DNA methylation profiling for diagnosis, prognosis, and treatment. | Neuro Oncol | 2023 |
| 37500667 | MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomas. | Nat Commun | 2023 |
| 38026572 | Reference on copy number variations in pleomorphic xanthoastrocytoma: Implications for diagnostic approach. | Free Neuropathol | 2023 |
| 37561227 | Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype: case series of a new entity. | Brain Tumor Pathol | 2023 |
| 37737691 | A Novel Type of IDH-wildtype Glioma Characterized by Gliomatosis Cerebri-like Growth Pattern, TERT Promoter Mutation, and Distinct Epigenetic Profile. | Am J Surg Pathol | 2023 |
| 37609137 | Epigenetic neural glioblastoma enhances synaptic integration and predicts therapeutic vulnerability. | bioRxiv | 2023 |
| 37500667 | MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomas. | Nat Commun | 2023 |
| 36959034 | Corrigendum to 'Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry' [Eur J Cancer 180 (2023) 71-84]. | Eur J Cancer | 2023 |
| 37348162 | DNA methylation-based classifier differentiates intrahepatic pancreato-biliary tumours. | EBioMedicine | 2023 |
| 37183219 | Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells. | J Neurooncol | 2023 |
| 37279174 | Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline. | Neuro Oncol | 2023 |
| 37075810 | LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patients. | Neuro Oncol | 2023 |
| 36542877 | Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry. | Eur J Cancer | 2023 |
| 36734226 | Adult intracranial ependymoma-relevance of DNA methylation profiling for diagnosis, prognosis, and treatment. | Neuro Oncol | 2023 |
| 36632791 | EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection. | Neuro Oncol | 2023 |
| 36928815 | Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology. | Nat Med | 2023 |
| 36271929 | Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1. | Acta Neuropathol | 2023 |
| 35868257 | DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patients. | Neuro Oncol | 2023 |
| 36356895 | Rare embryonal and sarcomatous central nervous system tumours: State-of-the art and future directions. | Eur J Med Genet | 2023 |
| 34564861 | Mucosal melanomas of different anatomic sites share a common global DNA methylation profile with cutaneous melanoma but show location-dependent patterns of genetic and epigenetic alterations. | J Pathol | 2022 |
| 36107362 | The utility of DNA methylation analysis in elderly patients with pilocytic astrocytoma morphology. | J Neurooncol | 2022 |
| 35908833 | EANO - EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors. | Neuro Oncol | 2022 |
| 35901673 | Long-term follow-up of surgical intervention pattern in pediatric low-grade gliomas: report from the German SIOP-LGG 2004 cohort. | J Neurosurg Pediatr | 2022 |
| 35380708 | Comprehensive profiling of myxopapillary ependymomas identifies a distinct molecular subtype with relapsing disease. | Neuro Oncol | 2022 |
| 35749951 | DNA methylation-based machine learning classification distinguishes pleural mesothelioma from chronic pleuritis, pleural carcinosis, and pleomorphic lung carcinomas. | Lung Cancer | 2022 |
| 36201019 | Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusions. | Acta Neuropathol | 2022 |
| 36119502 | [<sup>68</sup>Ga]Ga-PSMA PET/MRI, histological PSMA expression and preliminary experience with [<sup>177</sup>Lu]Lu-PSMA therapy in relapsing high-grade glioma. | Front Oncol | 2022 |